West Pharmaceutical Services (BSP:W2ST34) Buyback Yield % : 3.72 (As of Apr. 25, 2025)

View and export this data going back to 2021. Start your Free Trial

What is West Pharmaceutical Services Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

West Pharmaceutical Services's current buyback yield was 3.72%.

West Pharmaceutical Services Buyback Yield % Historical Data

The historical data trend for West Pharmaceutical Services's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Pharmaceutical Services Buyback Yield % Chart

West Pharmaceutical Services Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buyback Yield %

Get a 7-Day Free Trial

0.44

1.20

1.75

2.43

West Pharmaceutical Services Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Buyback Yield %	Get a 7-Day Free Trial															2.26	2.78	3.17	2.39	-

Competitive Comparison of West Pharmaceutical Services's Buyback Yield %

For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

West Pharmaceutical Services's Buyback Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where West Pharmaceutical Services's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

West Pharmaceutical Services Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

West Pharmaceutical Services's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (-3456.827	+	0)	/	142271.84994
	=	2.43%

West Pharmaceutical Services's annualized Buyback Yield for the quarter that ended in Mar. 2025 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (-2414.676	+	0)		/	98627.9408
	=	2.45%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

West Pharmaceutical Services Buyback Yield % Related Terms

Thank you for viewing the detailed overview of West Pharmaceutical Services's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

West Pharmaceutical Services Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (BSP:W2ST34) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

WST:USA WPS:Germany

Address

530 Herman O. West Drive, Exton, PA, USA, 19341-1147

Website

https://www.westpharma.com

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

West Pharmaceutical Services Headlines

No Headlines